Novonesis (Novozymes) B

NZM2

Company Profile

  • Business description

    Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs more than 11,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

  • Contact

    Krogshoejvej 36
    Bagsvaerd2880
    DNK

    T: +45 44460000

    https://www.novonesis.com

  • Sector

    Basic Materials

    Stock type

    Cyclical

  • Industry

    Specialty Chemicals

    Fiscal Year End

    31 December 2026

    Employees

    11,641

Stocks News & Analysis

stocks

ASX share undervalued despite margin woes

Short term margin pressure yet shares remain undervalued on improved outlook.
stocks

A better way to predict long-term stock returns

A value-weighted version of the CAPE ratio corrects a structural flaw and delivers stronger forecasts of long-term stock returns.
stocks

Five star stock added to August best ideas list

Morningstar analysts hand pick this undervalued opportunity for their August global best ideas.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,853.3070.60-0.79%
CAC 408,117.7861.99-0.76%
DAX 4025,440.81127.75-0.50%
Dow JONES (US)52,421.20152.09-0.29%
FTSE 10010,697.5747.130.44%
HKSE24,818.0699.54-0.40%
NASDAQ26,186.41146.62-0.56%
Nikkei 22564,004.66511.670.81%
NZX 50 Index13,495.2765.42-0.48%
S&P 5007,619.9837.00-0.48%
S&P/ASX 2008,671.7078.20-0.89%
SSE Composite Index3,883.242.10-0.05%

Market Movers